Gilead Sciences Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (18)

Latest Articles

About This Stock More About This Stock
Hot Bargains In Big Biotech
Article By: Bret Jensen
Tuesday, November 18, 2014 12:00 PM EDT
It has been an eventful year in the big pharma and biotech space, and a lot is happening in this space that biotech investors should take note of.
In this article: AGN, AVNR, REGN, AMGN, BIIB, CELG, GILD, ABBV
Read
Rayno Life Science Small Cap Picks: CLDX, PACB, FMI…Update-1
Article By: Rod Raynovich
Monday, November 17, 2014 12:00 PM EDT
Recent small cap picks.
In this article: ALXN, CLDX, GHDX, ILMN, REGN, SGEN, ALKS, GILD, PACB, KPTI, FMI, FCSC
Read
Why Apple Pay Is A Game Changer
Article By: Bret Jensen
Thursday, November 13, 2014 9:00 AM EDT
Apple is a revolutionary company. Starting with the iPod and iTunes, Apple has continually turned industries on their heads reaping big profits along the way. Now setting their targets on the mobile payments industry, Apple is about to hit another grand slam.
In this article: M, P, PAY, AAPL, GILD, NXPI, WFM, GOOGL
Read
Achillion Pharmaceuticals Continues To Impress With Hepatitis C Results In A Combination Study
Article By: Terry Chrisomalis
Tuesday, November 11, 2014 10:55 AM EDT
ACH-3102 showed 100% Hepatitis C virus clearance in combination with Gilead's sofosbuvir.
In this article: ACHN, GILD
Read
Consider The 2-3x Upside In This Most Overlooked Hepatitis B Stock
Article By: PropThink
Tuesday, November 4, 2014 1:32 PM EDT
GlobeImmune IPO’d in June to little fanfare and has underperformed the biotech sector considerably since then. A key driving event in the next six months should put it back on the radar.
In this article: ALNY, CELG, GILD, ARWR, GBIM
Read
Third Quarter Earnings Season Halftime Report
Article By: Leigh Drogen
Thursday, October 30, 2014 1:35 PM EDT
Yes, we are technically past the halfway mark for S&P 500 earnings season, with 322 companies reporting at this point, but here is a look at what the results have told us thus far.
In this article: T, VZ, AMZN, EBAY, GILD, GOOG, MSFT, NFLX, SPY, FB, TWTR, GOOGL
Read

Latest Tweets for $GILD

No tweets yet!

PARTNER HEADLINES